{
    "2018-07-30": [
        [
            {
                "time": "2018-07-31",
                "original_text": "What to Expect from Incyte’s Q2 2018 Earnings on July 31",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Q2 2018 Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "How Celgene’s Otezla and Abraxane Did in Q2 2018",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Otezla",
                        "Abraxane",
                        "Q2 2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "A Look at Celgene’s Financials in Q2 2018",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Financials",
                        "Q2 2018"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "WisdomTree U.S. Dividend ex-Financials Fund -- Insider Buying Index Registering 10.2%",
                "features": {
                    "keywords": [
                        "WisdomTree",
                        "U.S. Dividend ex-Financials Fund",
                        "Insider Buying",
                        "Index Registering 10.2%"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly And Co.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Eli Lilly",
                        "report"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "Lilly Announces Extension of Cancer Research Collaboration with Dana-Farber Cancer Institute",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Cancer Research",
                        "Dana-Farber Cancer Institute",
                        "Extension"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}